An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Schizophrenia
Interventions
DRUG

PF-02545920

5 mg tablet every 12 hours for 28 days

DRUG

PF-02545920

15 mg tablet every 12 hours for 28 days

DRUG

Placebo

One tablet/capsule every 12 hours for 28 days

DRUG

Risperidone

3 mg capsule every 12 hours for 28 days

Trial Locations (46)

11423

Comprehensive Neuroscience, Inc., Hollis

19139

CRI Worldwide, LLC, Philadelphia

20016

Comprehensive Neuroscience, Incorporated, Washington D.C.

20850

CBH Health, LLC, Rockville

30308

Atlanta Center for Medical Research, Atlanta

32751

Florida Clinical Research Center, LLC, Maitland

32810

Lakeside Behavioral Healthcare, Orlando

34208

Florida Clinical Research Center, LLC, Bradenton

36006

Poltava Regional Clinical Psychiatric Hospital n.a. O.F. Maltsev, Poltava

49005

"Municipal Establishment Dnipropetrovsk Regional Clinical Hospital n.a. Mechnikov", Dnipropetrovsk

49115

"Municipal Establishment Dnipropetrovsk Regional Clinical Psychiatric Hospital", Dnipropetrovsk

60169

Alexian Brothers Behavioral Health Hospital, Hoffman Estates

Alexian Brothers Center for Psychiatric Research, Hoffman Estates

Chinmay K. Patel, D.O., Hoffman Estates

63118

St. Louis Clinical Trials, LC, St Louis

68159

Zentralinstitut fuer Seelische Gesundheit, Mannheim

70601

Lake Charles Memorial Hospital, Lake Charles

70629

Lake Charles Clinical Trials, Lake Charles

72201

K & S Professional Research Services, LLC, Little Rock

73488

Kherson Regional Psychiatric Hospital, Department #3, Stepanivka, Kherson

75115

InSite Clinical Research, DeSoto

77007

Bayou City Research, Ltd., Houston

77081

Behavioral Hospital - Bellaire, Houston

78731

FutureSearch Trials, Austin

78745

TexasNeuroRehab Center, Austin

78754

Community Clinical Research, Austin

90502

Collaborative Neuroscience Network, Inc., Torrance

90505

Del Amo Hospital, Torrance

90723

California Clinical Trials Medical Group, Paramount

LaPaz Geropsychiatric Center, Paramount

90806

Ocean View Psychiatric Health Facility, Long Beach

90822

Long Beach VA Healthcare System, Long Beach

91045

Lugansk Regional Clinical Psychoneurological Hospital, Luhansk

92025

Early Phase Investigational Center, Escondido

Synergy Clinical Research Center of Escondido, Escondido

92123

Sharp Mesa Vista Hospital, San Diego

92701

Neuropsychiatric Research Center of Orange County, Santa Ana

92801

Leisure Court Center, Anaheim

92845

Collaborative Neuroscience Network, Inc., Garden Grove

92868

University of California Irvine Medical Center, Orange

98033

Eastside Therapeutic Resource, Kirkland

98034

Fairfax Hospital, Kirkland

08046

CRI Worldwide, LLC, Willingboro

Lourdes Medical Center of Burlington County, Willingboro

02660

Kyiv City Psychoneurological Hospital #2, Kyiv

04080

Kyiv City Clinical Psychoneurological Hospital #1, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY